logo
Market statusData NSENot investment advice
GUJARAT KIDNEY N SUP SP L

GUJARAT KIDNEY N SUP SP L Latest Share Price (GKSL)

TechnicalsTV Chart
₹187.76
0.39+0.21%
Overall Score45/100
Day range186
₹187.76
191
52-week98
₹187.76
210
Above low+90.9%
Below high10.5%
Range position80%
Open187.02
Prev Close187.37
Bid187.73174
Ask187.79109

TODAY IN ONE LINE

GKSL is little changed at ₹187.76 — a quiet consolidation day.

With a market cap of ₹1,486.59 Cr., it trades at a P/E of 93.81. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume435.2K−84%vs 20D avg
Price Band20
Lower Band151.72
Upper Band227.56
Tick Size0.01
Daily Volatility1.87%
Annualised Vol35.73%
Market Cap₹1,486.59 Cr.
Promoter71.45%
Face Value₹2
Fwd P/E—
PEG—
EV/EBITDA35.78
P/S9.65
ROA—
Beta—
Div Payout—
THE STOCK SCORE
Overall Score45/100
Updated 31 Dec

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

GUJARAT KIDNEY N SUP SP L flags & news 

Key strengths, potential risks, and recent updates.

✅ 5 green flags🚩 2 red flags

Green Flags

  • ●Healthy Operating MarginsOPM is structurally strong at 18.0%
  • ●High Promoter HoldingPromoters hold 71.5% skin-in-the-game
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.06x
  • ●FII AccumulationFII holding increased by 1.65% QoQ
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • ●Poor Capital ReturnsLow ROE of 7.6%
  • ●Expensive ValuationTrading at a high P/E ratio of 65.0x

Latest GUJARAT KIDNEY N SUP SP L News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

GUJARAT KIDNEY N SUP SP L valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for GUJARAT KIDNEY N SUP SP L, framed against the sector median so the premium or discount is obvious at a glance.

GUJARAT KIDNEY N SUP SP L trades at a P/E of 93.81× and P/B of 5.89×.

Key MetricsMarket + reported · 19 Oct 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹1,486.59 Cr.
P/E Ratio
93.81
P/B Ratio
5.89
EPS
₹0.66
Profitability

Profitability

ROE
7.58%
ROCE
8.56%
Net Margin
20.5%
Op Margin
18%
Growth

Growth

EPS YoY
—
Revenue YoY
—
Qtr Sales
—
Qtr Profit
—
Financial Health

Financial Health

Debt / Equity
0.06
Book Value
₹32.31
Div Yield
—
Promoter Holding
71.45%
Technicals

GUJARAT KIDNEY N SUP SP L technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for GUJARAT KIDNEY N SUP SP L — derived from the latest tape, not yesterday's close.

GUJARAT KIDNEY N SUP SP L last traded at ₹187.76 with an intraday range of ₹186.02–₹191 — latest indicator, pivot and CPR signals below.

Last updated: 21 October 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹187.76
LevelPrice (₹)Distance% Δ
R4200.46+12.70+6.76%
R3195.48+7.72+4.11%
R2193.24+5.48+2.92%
R1190.50+2.74+1.46%
PIVOT188.260.500.27%
CURRENT187.76——
S1185.52-2.24-1.19%
S2183.28-4.48-2.39%
S3180.54-7.22-3.85%
S4175.56-12.20-6.50%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 188.01P: 188.26TC: 188.51
R1
R2
R3
R4
indicator
LTP: 187.76
PDH: 193.39
PDL: 186.56
● Market Sentiment

GKSL is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Average

● Opening Range

Day's range: ₹186.14–₹189

● Price Position

Trading Inside opening range

Financials

GUJARAT KIDNEY N SUP SP L financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for GUJARAT KIDNEY N SUP SP L — consolidated or standalone — with margins, YoY growth and key ratios inline.

GUJARAT KIDNEY N SUP SP L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,486.59 Cr. and reported EPS of ₹0.66.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026May 2026
Revenue from Operations82
82
▲ 0.0%
Other Income1
1
▲ 0.0%
Total Income83
83
▲ 0.0%
9
9
▲ 0.0%
Gross ProfitDerived73
73
▲ 0.0%
Gross Margin %Derived88.89%
88.89%
46
46
▲ 0.0%
EBITDA (Operating Profit)Derived27
27
▲ 0.0%
OPM %Derived32.85%
32.85%
7
7
▲ 0.0%
Profit Before Tax (PBT)21
21
▲ 0.0%
4
4
▲ 0.0%
Effective Tax %Derived20.83%
20.83%
Total Profit for Period17
17
▲ 0.0%
Less: Non-controlling Interests1
1
▲ 0.0%
Net Profit (Owner's PAT)Derived15
15
▲ 0.0%
Net Profit Margin %Derived18.90%
18.90%
Earnings Per Share (EPS ₹)1.97
1.97
▲ 0.0%
Diluted Shares Outstanding (Cr)8
8
▲ 0.0%
Other Comprehensive Income (Net of Tax)-0
-0
▲ 0.0%
Total Expenses (incl. D&A & Interest)62
62
▲ 0.0%
Material Cost % of RevenueDerived11.11%
11.11%
Employee Cost % of RevenueDerived16.63%
16.63%
Other Cost % of RevenueDerived39.41%
39.41%
Interest Coverage (x)Derived11.84x
11.84x
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

GUJARAT KIDNEY N SUP SP L segment analysis : revenue and profit mix.

Disclosed business segments at GUJARAT KIDNEY N SUP SP L with their share of revenue and profit, switchable between consolidated and standalone reporting.

GUJARAT KIDNEY N SUP SP L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for GUJARAT KIDNEY N SUP SP L.

Our AI distills the core fundamental drivers supporting GUJARAT KIDNEY N SUP SP L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 122 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Return-quality risk. ROE below 8% would indicate weaker capital compounding.

Shareholding

GUJARAT KIDNEY N SUP SP L shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in GUJARAT KIDNEY N SUP SP L — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

FII6.53%↑1.65%
Promoters71.45%
DII0.26%↓0.30%
Public21.77%↓1.33%

Ownership Distribution

Foreign Institutions
6.53%
Promoters
71.45%
Domestic Institutions
0.26%
Retail & Public
21.77%

Category Trends

Foreign Institutions Breakdown
Total Holding: 6.53%
Net Change: +1.65%
Category Total6.53%
Total Holding6.53%
Net Change+1.65%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 3.50%, but category aggregate is 6.53%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
GOLDMAN SACHS INVESTMENTS (MAURITIUS) I LTD
3.50%
3.50%
+3.50%
Sep 2026
CRAFT EMERGING MARKET FUND PCC- CITADEL CAPITAL FUND
0.00%
1.67%
-1.67%
Sep 2026
VENUS INVESTMENTS VCC - VENUS STELLAR FUND
0.00%
0.00%
0.00%
Sep 2026
ASTORNE CAPITAL VCC - ARVEN
0.00%
0.00%
0.00%
Sep 2026
CRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUND
0.00%
0.00%
0.00%
Sep 2026
Peers

GUJARAT KIDNEY N SUP SP L peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — GUJARAT KIDNEY N SUP SP L is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
MANIPAL HEALTH ENTERPRI L
₹82,855.61 Cr
Best Profit Growth
SHUKRA PHARMACEUTICALS L
742.72 %
Highest Dividend Yield
JENBURKT PHARMACEUTICAL L
2.24 %

Peer Comparison

Company Name
09 · Chart Patterns

GUJARAT KIDNEY N SUP SP L chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for GUJARAT KIDNEY N SUP SP L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

GUJARAT KIDNEY N SUP SP L delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for GUJARAT KIDNEY N SUP SP L over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in GUJARAT KIDNEY N SUP SP L stood at 52.8% of traded volume, against a 20-day average of 36.7%.

Avg Delivery (20D)36.7%+16.1 ppt latest vs avg
Highest Delivery61.7%on 24 Sept
Avg Volume (20D)27.79 L20-day run-rate
Conviction Trend↓ Weakening+16.1 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

GUJARAT KIDNEY N SUP SP L announcements: results, concalls, ratings, M&A.

Filings GUJARAT KIDNEY N SUP SP L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

GUJARAT KIDNEY N SUP SP L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 53 documents below.

  1. 05 Oct 2026Certificate under SEBI (Depositories and Participants) Regulations, 2018View PDF

    Certificate under SEBI (Depositories and Participants) Regulations, 2018

    Gujarat Kidney And Super Speciality Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  2. 29 Sept 2026Shareholders meetingView PDF

    Shareholders meeting

    Gujarat Kidney And Super Speciality Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28,…

  3. 28 Sept 2026Shareholders meetingView PDF

    Shareholders meeting

    Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026

  4. 26 Sept 2026Trading WindowView PDF

    Trading Window

    Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider…

  5. 04 Sept 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication about mailing Annual report

Corporate Actions

GUJARAT KIDNEY N SUP SP L dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue GUJARAT KIDNEY N SUP SP L has declared, sequenced by announce and record date.

GUJARAT KIDNEY N SUP SP L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About GUJARAT KIDNEY N SUP SP L: business, sector, key facts.

What GUJARAT KIDNEY N SUP SP L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

GUJARAT KIDNEY N SUP SP L is a listed Indian equity, listed as NSE: GKSL, BSE: 544666.

company facts
Employees—
Sector—
Headquarters—
Market Cap₹1,486.59 Cr.
Listed OnNSE · BSE
leadership8 on record
Dr. Hardikbhai Jamandas Gajera
Senior Nephrologist & Head of Department
Dr. Kunal Harishbhai Shah
Senior Anaesthetist & Head of Department
Dr. Nikita Yashvantsinh Bharpoda
Senior Gynaecologist & Head of Department
Dr. Vivek Laxmanbhai Patel
Senior Orthopaedic Surgeon & Head of Department
Mr. Bhartiben Pragnesh Bharpoda
Whole-time Director
Mr. Pragnesh Yashwantsinh Bharpoda
Chairman & MD
Ms. Bhavikaben Mitesh Patel
Chief Financial Officer
Ms. Vishakha Mahesh Phadke
Company Secretary & Compliance Officer
§ ∞ · Plainly Answered

Questions investors ask about GUJARAT KIDNEY N SUP SP L (GKSL).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of GUJARAT KIDNEY N SUP SP L (GKSL)?

The current share price of GUJARAT KIDNEY N SUP SP L (GKSL) is ₹187.76. Today, the stock has gained by ₹0.39 (0.21%), trading in a range of ₹186.02 to ₹191.00. The stock opened at ₹187.02 with a trading volume of 4,35,243 shares.

02Is GUJARAT KIDNEY N SUP SP L stock a good investment for long-term?

GUJARAT KIDNEY N SUP SP L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,486.59 Cr., P/E ratio of 93.81, ROE of 7.58%, and ROCE of 8.56%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of GUJARAT KIDNEY N SUP SP L stock?

The 52-week high price of GUJARAT KIDNEY N SUP SP L (GKSL) is ₹209.80, while the 52-week low is ₹98.36. Currently trading at ₹187.76, the stock is 90.89% above its 52-week low and 10.51% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy GUJARAT KIDNEY N SUP SP L stock at the current price?

Whether to buy GUJARAT KIDNEY N SUP SP L stock at ₹187.76 depends on multiple factors. The stock is currently trading with a P/E ratio of 93.81 and P/B ratio of 5.89. Today's performance shows a gain of 0.21%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of GUJARAT KIDNEY N SUP SP L and when is the next dividend?

GUJARAT KIDNEY N SUP SP L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹187.76, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of GUJARAT KIDNEY N SUP SP L?

GUJARAT KIDNEY N SUP SP L's key financial metrics include: P/E Ratio: 93.81, P/B Ratio: 5.89, ROE: 7.58%, ROCE: 8.56%, Dividend Yield: 0%, EPS: ₹0.66, Book Value: ₹32.31, and Debt-to-Equity: 0.06. The company's market cap stands at ₹1,486.59 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is GUJARAT KIDNEY N SUP SP L stock performing today in the market?

GUJARAT KIDNEY N SUP SP L stock opened at ₹187.02 and is currently trading at ₹187.76, showing a gain of ₹0.39 (0.21%). The intraday high is ₹191.00 and low is ₹186.02. The trading volume stands at 4,35,243 shares, indicating moderate market participation today.

08What is the P/E ratio of GUJARAT KIDNEY N SUP SP L and what does it indicate?

GUJARAT KIDNEY N SUP SP L has a Price-to-Earnings (P/E) ratio of 93.81, which means investors are willing to pay 93.81 for every ₹1 of earnings. With an EPS of ₹0.66, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about GUJARAT KIDNEY N SUP SP L (GKSL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.